Items tagged with Research and development
Tackling drug-resistant infections globally: final report and recommendations (post with simple image)
The Review on Antimicrobial Resistance released its final report and recommendations warning that antimicrobial-resistant infections such as drug-resistant tuberculosis could kill 10 million people a year by 2050 without an urgent expansion of resources and funds.
The time is now: how we can start taking action on TB R&D (post with simple image)
Treatment Action Group released a new resource, Breathing Life into Flatlined U.S. Government Funding for Tuberculosis Research: FY 2017–2020 Allocations and Recommendation, to spark and support ongoing advocacy on TB R&D.
Mike Frick's plenary talk at TB2016 in Durban (post with simple image)
Mike Frick's plenary talk delivered at TB2016 Durban, South Africa, July 16, 2016.
As U.N. General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs (post with simple image)
New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs.
U.N. High-Level Panel on Access to Medicines releases final report (post with simple image)
United Nations Secretary-General’s High-Level Panel on Access to Medicines calls for new deal to close the health innovation and access gap.
Funding for TB research falls to lowest level in seven years (post with simple image)
Treatment Action Group’s Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose shows that the world spent US$620.6 million on TB research and development in 2015, the lowest level of funding since 2008.
Petition to BRICS countries to triple funding for TB R&D (post with simple image)
>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response.
Advocates encourage prioritization of drug-resistant TB research (post with simple image)
TB advocates encourage the Global Antimicrobial Resistance Innovation Fund to prioritize research and development for drug-resistant TB.
Advocates encourage Danaher to continue investments in Cepheid’s TB products (post with simple image)
TB advocates encourage Danaher, a holdings company that recently acquired Cepheid, to prioritize the continued development of critical Cepheid products for TB.
Public health groups welcome Johns Hopkins University and Medicines Patent Pool agreement for development of promising new TB drug (post with simple image)
While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability.
Page 12 of 13 · Total posts: 0←First 11 12 13 Last→